Last edition
News about Global Pharma
Supriya Lifescience Inaugurates New 5 MWp Solar Facility in Maharashtra
This initiative is part of the ongoing program in which Supriya Lifesciences is committed to reducing carbon footprint from its operations.
Global Pharma | 20/03/2025 | By Aishwarya | 605
Indegene Inaugurates New Center in London to Expand Globally
Indegene’s Europe-based clients can now benefit from this center as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach.
Global Pharma | 20/03/2025 | By Aishwarya | 379
Marksans Pharma’s UK subsidiary Relonchem has received UK MHRA approval for Baclofen 10 mg tablets, strengthening its presence in the UK pharmaceutical market.
Global Pharma | 19/03/2025 | By Manvi | 866
Kincell Bio Welcomes Larry Pitcher as Chief Operating Officer
Most recently, Larry was VP and GM for Catalent’s Gene Therapy Sites in MD, their largest operation, which accounted for a significant share of the company’s annual revenue.
Global Pharma | 19/03/2025 | By Aishwarya | 231
Shilpa Biologicals, mAbTree Biologics to Develop Immuno-Oncology Therapy
Under the terms of the agreement, Shilpa Biologicals will support the entire development process, including first-in-human clinical trials, while also ensuring long-term commercial supply through its Good Manufacturing Practice (GMP) manufacturing capabilities.
Global Pharma | 19/03/2025 | By Aishwarya | 705
Delpharm to Advance its Sterile Injectable Manufacturing Facility in Boucherville
The signing of a 10-year agreement between Delpharm and Sandoz establishes a foundation for ensuring a stable and reliable supply of critical medicines for Canadians, thereby enhancing the country's healthcare autonomy amid global supply chain disruptions.
Global Pharma | 19/03/2025 | By Aishwarya | 337
TAF 2025 Calls for Stricter Laws to Curb Drug Counterfeiting
In a major push to protect India’s industries, stakeholders at the 6th edition of the Traceability and Authentication Forum (TAF 2025) called for stricter anti-counterfeiting laws and advanced traceability measures.
Global Pharma | 19/03/2025 | By Aishwarya | 345
Clario, a provider of endpoint data solutions to the clinical trial industry, announced they have acquired NeuroRx, a company in imaging analysis with expertise in multiple sclerosis.
Global Pharma | 18/03/2025 | By Manvi | 311
Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies
Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.
Global Pharma | 18/03/2025 | By Aishwarya | 243
AstraZeneca Signs License Deal with Alteogen for ALT-B4
Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets.
Global Pharma | 18/03/2025 | By Aishwarya | 556
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy